Combining MucilAir™ and Vitrocell® Powder Chamber for the In Vitro Evaluation of Nasal Ointments in the Context of Aerosolized Pollen

Combining MucilAir™ and Vitrocell® Powder Chamber for the In Vitro Evaluation of Nasal Ointments in the Context of Aerosolized Pollen

Hay fever is notoriously triggered when nasal mucosa is exposed to allergenic pollen. One possibility to overcome this pollen exposure may be the application of an ointment with physical protective effects. In this context, we have investigated Bepanthen® Eye and Nose Ointment and the ointme...

Full description

Bibliographic Details
Main Authors: Julia Metz, Katharina Knoth, Henrik Groß, Claus-Michael Lehr, Carolin Stäbler, Udo Bock, Marius Hittinger
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Pharmaceutics
Subjects:
allergy prevention
pollen
aerosol deposition in vitro system
nasal mucosa
Bepanthen® Eye and Nose Ointment
Online Access:http://www.mdpi.com/1999-4923/10/2/56

Similar Items

Similar Items